The National Institutes of Health (NIH) reports that a common and potent diuretic might hold the key to lowering the prevalence of Alzheimer’s disease, particularly in people who are genetically predisposed to the illness.
https://www.pharmalive.com/wp-content/uploads/2021/10/NIH-Believes-Common-Diuretic-Drug-Could-Lower-Risk-of-Alzheimers-BioSpace-10-12-21.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2021-10-12 11:47:582021-10-12 14:54:04NIH Believes Common Diuretic Drug Could Lower Risk of Alzheimer’s